Authors:
DURAND I
BEYLOTBARRY M
WEILL FX
DOUTRE MS
BEYLOT C
Citation: I. Durand et al., DISSEMINATED CUTANEOUS LEISHMANIASIS REVE ALING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Annales de dermatologie et de venereologie, 125(4), 1998, pp. 268-270
Authors:
BEYLOTBARRY M
DOUTRE MS
VERGIER B
PELLEGRIN JL
JOLY P
LENG B
BEYLOT C
Citation: M. Beylotbarry et al., LICHENOID PARANEOPLASTIC PEMPHIGUS ASSOCIATED WITH A LOW-GRADE NODAL LYMPHOMA, Annales de dermatologie et de venereologie, 125(10), 1998, pp. 720-723
Authors:
VERGIER B
BEYLOTBARRY M
PULFORD K
MICHEL P
BOSQ J
DEMURET A
BEYLOT C
DELAUNAY MM
AVRIL MF
DALAC S
BODEMER C
JOLY P
GROPPI A
DEMASCAREL A
BAGOT M
MASON DY
WECHSLER J
MERLIO JP
Citation: B. Vergier et al., STATISTICAL EVALUATION OF DIAGNOSTIC AND PROGNOSTIC FEATURES OF CD30-A CLINICOPATHOLOGICAL STUDY OF 65 CASES( CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS ), The American journal of surgical pathology, 22(10), 1998, pp. 1192-1202
Authors:
MARLIERE V
BEYLOTBARRY M
DOUTRE MS
FURIOLI M
VERGIER B
DUBUS P
MERLIO JP
BEYLOT C
Citation: V. Marliere et al., LYMPHOMATOID CONTACT-DERMATITIS CAUSED BY ISOPROPYL-DIPHENYLENEDIAMINE - 2 CASES, Journal of allergy and clinical immunology, 102(1), 1998, pp. 152-153
Authors:
ROUSSEAU L
BEYLOTBARRY M
DOUTRE MS
BEYLOT C
Citation: L. Rousseau et al., CUTANEOUS SARCOIDOSIS SUCCESSFULLY TREATED WITH LOW-DOSES OF THALIDOMIDE, Archives of dermatology, 134(8), 1998, pp. 1045-1046
Authors:
BARAN R
BELAICH S
BEYLOT C
BONNETBLANC JM
CRIBIER B
DANIEL F
DUBERTRET L
ESCANDE JP
KALIS B
MEYNADIER J
PRIVAT Y
DEPROST Y
REVUZ J
SCHUBERT B
SOUTEYRAND P
ZAGULA M
Citation: R. Baran et al., COMPARATIVE MULTICENTER DOUBLE-BLIND-STUDY OF TERBINAFINE (250 MG PERDAY) VERSUS GRISEOFULVIN (1 G PER DAY) IN THE TREATMENT OF DERMATOPHYTE ONYCHOMYCOSIS, Journal of dermatological treatment, 8(2), 1997, pp. 93-97
Authors:
DOUTRE MS
BEYLOTBARRY M
BEYLOT C
BAQUEY A
Citation: Ms. Doutre et al., DISSEMINATED LUPUS-ERYTHEMATOSUS AND MONO CLONAL IMMUNOGLOBULIN - A STUDY IN 90 PATIENTS, La Presse medicale, 26(7), 1997, pp. 321-321
Authors:
DOUTRE MS
BEYLOTBARRY M
BEYLOT C
DUBUS P
LAFONT ME
BROUSTET A
MERLIO JP
Citation: Ms. Doutre et al., CUTANEOUS LOCALIZATION OF CHRONIC LYMPHOCYTIC-LEUKEMIA AT THE SITE OFCHICKENPOX, Journal of the American Academy of Dermatology, 36(1), 1997, pp. 98-99
Authors:
BERNARD P
VAILLANT L
MARTIN C
BEYLOT C
QUENTIN R
TOURON D
Citation: P. Bernard et al., PRISTINAMYCIN VERSUS OXACILLIN IN THE TRE ATMENT OR SUPERFICIAL PYODERMA - MULTICENTRIC, RANDOMIZED STUDY IN 293 OUT-PATIENTS, Annales de dermatologie et de venereologie, 124(5), 1997, pp. 384-389
Authors:
BEYLOTBARRY M
VERGIER B
PULFORD K
BOSQ MJ
DEMURET A
BEYLOT C
DELAUNAY MM
AVRIL MF
DALAC S
BODEMER C
JOLY P
BAGOT M
DEMASCAREL A
MANSON DY
WECHSLER J
MERLIO JP
Citation: M. Beylotbarry et al., DIFFERENT PROGNOSIS BETWEEN CUTANEOUS AND SYSTEMIC CD30+ LYMPHOPROLIFERATIVE DISORDERS IS NOT SUPPORTED BY BIOLOGICAL DATA, Journal of investigative dermatology, 109(3), 1997, pp. 484-484
Authors:
DUBUS P
VERGIER B
BEYLOTBARRY M
DELAUNAY MM
GOUSSOT JF
BEYLOT C
DEMASCAREL A
FARCET JP
MERLIO JP
Citation: P. Dubus et al., CONTRIBUTION OF HISTOPATHOLOGICAL AND MOLECULAR ANALYSES TO THE DIAGNOSIS OF CUTANEOUS B-CELL INFILTRATES, Journal of investigative dermatology, 109(3), 1997, pp. 492-492
Citation: C. Beylot, ORAL-CONTRACEPTIVES AND CYPROTERONE-ACETATE IN FEMALE ACNE TREATMENT, Journal of investigative dermatology, 108(3), 1997, pp. 132-132
Authors:
DUBUS P
VERGIER B
BEYLOTBARRY M
DELAUNAY MM
GOUSSOT JF
BEYLOT C
DEMASCAREL A
FARCET JP
MERLIO JP
Citation: P. Dubus et al., CONTRIBUTION OF HISTOPATHOLOGIC AND MOLECULAR ANALYSES TO THE DIAGNOSIS OF CUTANEOUS B-CELL INFILTRATES, Modern pathology, 9(12), 1996, pp. 1147-1155